These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Challenges in the diagnosis and management of immune-mediated necrotising myopathy (IMNM) in a patient on long-term statins. Khan F; Brady S; Kuttikat A Rheumatol Int; 2023 Feb; 43(2):383-390. PubMed ID: 36260115 [TBL] [Abstract][Full Text] [Related]
32. Statins and myositis: the role of anti-HMGCR antibodies. Selva-O'Callaghan A; Alvarado-Cardenas M; Marin A; Pinal-Fernandez I Expert Rev Clin Immunol; 2015; 11(12):1277-9. PubMed ID: 26492593 [TBL] [Abstract][Full Text] [Related]
33. Atypical skin conditions of the neck and back as a dermal manifestation of anti-HMGCR antibody-positive myopathy. Kurashige T; Nakamura R; Murao T; Mine N; Sato M; Katsumata R; Kanaya Y; Dodo Y; Sugiura T; Ohshita T BMC Immunol; 2024 May; 25(1):30. PubMed ID: 38734636 [TBL] [Abstract][Full Text] [Related]
34. [Dermatomyositis-like syndrome revealing statin-induced necrotizing autoimmune myopathy with anti-HMGCR antibodies]. Merlant M; Fite C; Kottler D; Maisonobe L; Dossier A; Deschamps L; Descamps V Ann Dermatol Venereol; 2019 Sep; 146(8-9):550-556. PubMed ID: 30929872 [TBL] [Abstract][Full Text] [Related]
35. Immune-Mediated Necrotizing Myopathy: Update on Diagnosis and Management. Basharat P; Christopher-Stine L Curr Rheumatol Rep; 2015 Dec; 17(12):72. PubMed ID: 26515574 [TBL] [Abstract][Full Text] [Related]
36. [Clinical and pathological characteristics of immune mediated necrotizing myopathy]. Yang HX; Tian XL; Jiang W; Li WL; Liu QY; Peng QL; Wang GC; Lu X Beijing Da Xue Xue Bao Yi Xue Ban; 2019 Dec; 51(6):989-995. PubMed ID: 31848492 [TBL] [Abstract][Full Text] [Related]
37. Treatment and outcomes in anti-HMG-CoA reductase-associated immune-mediated necrotising myopathy. Comparative analysis of a single-centre cohort and published data. Rademacher JG; Glaubitz S; Zechel S; Oettler M; Tampe B; Schmidt J; Korsten P Clin Exp Rheumatol; 2022 Feb; 40(2):320-328. PubMed ID: 35225222 [TBL] [Abstract][Full Text] [Related]
38. [Immune-mediated necrotizing myopathy associated with antibodies to hydroxy-methyl-glutaryl-coenzyme A reductase]. Hinschberger O; Lohmann C; Lannes B; Martzolff L; Vo BD; Jaeger-Bizet F; Ciobanu E; Kieffer P Rev Med Interne; 2014 Aug; 35(8):546-9. PubMed ID: 23910221 [TBL] [Abstract][Full Text] [Related]
39. Antibody levels correlate with creatine kinase levels and strength in anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathy. Werner JL; Christopher-Stine L; Ghazarian SR; Pak KS; Kus JE; Daya NR; Lloyd TE; Mammen AL Arthritis Rheum; 2012 Dec; 64(12):4087-93. PubMed ID: 22933019 [TBL] [Abstract][Full Text] [Related]
40. Statin-induced necrotizing myositis - a discrete autoimmune entity within the "statin-induced myopathy spectrum". Hamann PD; Cooper RG; McHugh NJ; Chinoy H Autoimmun Rev; 2013 Oct; 12(12):1177-81. PubMed ID: 23851103 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]